世界のマウスモデル市場動向及び予測（～2018）：タイプ別（近交系、ノックアウト、条件付け）、技術別（マイクロインジェクション、胚性幹細胞）、疾患別（腫瘍学、免疫学、CNS）、サービス別（繁殖、冷凍保存、検疫）、ケア製品別（カゴ、寝床、餌）...市場調査レポートについてご紹介

1 Introduction (Page No. – 35)
1.1 Markets Covered
1.2 Stakeholders
1.3 Research Methodology

2 Executive Summary (Page No. – 51)

3 Market Dynamics (Page No. – 60)
3.1 Drivers
3.1.1 Ongoing Innovations in Mice Models
3.1.2 Investments and Grants
3.1.3 Personalized Medicine to Fuel The Demand For Personalized Humanized Mice Models
3.1.4 Associations Propelling The Development of Embryonic Stem Cells (Es Cells) As Well As Knockout and Mutant Mice
3.1.5 Global Conferences and Meetings Stimulate Market Growth
3.1.6 Genetic Similarity of Mice to Humans
3.1.7 Advancements in Biotechnology and Biopharmaceutical Industries
3.1.8 Increase in R&D Activities in Pharmaceutical Industries
3.2 Threats
3.2.1 Advances in Zebrafish Model Development
3.2.2 Increased Usage of Rat Models
3.2.3 Increased Benefits From Cryopreservation Is Likely to Hamper The Demand For Mice Models
3.2.4 Alternative Methods to Animal Testing
3.3 Barriers
3.3.1 Regulations and Laws For Ethical Use of Animals in Research
3.4 Opportunities
3.4.1 Upsurge in Research Involving Humanized Mice
3.4.2 Increase In Monoclonal Antibody Production
3.5 Challenges
3.5.1 Need For Improved Mice Models

4 Market Share Analysis, By Key Players (Page No. – 76)

5 Mice Model Market Size (Page No. – 89)
5.1 Market By Type
5.1.1 Introduction
5.1.2 Inbred Mice
5.1.3 Outbred Mice
5.1.4 Hybrid/Congenic Mice
5.1.5 Spontaneous/Mutant Mice
5.1.6 Knockout Mice
5.1.7 Conditioned/Surgically Modified
5.2 Market By Technology
5.2.1 Introduction
5.2.2 Micro-Injection
5.2.3 Embryonic Stem Cell Injection
5.2.4 Nuclear Transferase Technology
5.2.5 Viruses/Vectors
5.2.6 Genetically Modified Sperms
5.2.7 Others
5.3 Market By Disease
5.3.1 Introduction
5.3.2 Oncology
5.3.3 Immunology and Inflammation
5.3.4 Diabetes
5.3.5 Cardiovascular
5.3.6 Central Nervous System
5.3.7 Metabolism and Regulation
5.3.8 Others
5.4 Market By Service
5.4.1 Introduction
5.4.2 Breeding
5.4.3 Cryopreservation
5.4.4 Quarantine
5.4.5 Rederivation
5.4.6 Genetic Testing
5.4.7 Model in Licensing
5.4.8 Others
5.5 Mice Care Products Market, By Segment
5.5.1 Introduction
5.5.2 Cages
5.5.3 Bedding
5.5.4 Feed
5.5.5 Others

6 Geographic Analysis (Page No. – 148)
6.1 Introduction
6.2 North America
6.2.1 Investments in The Development of Mice Models to Increase Their Application Areas
6.2.2 Growing Biomedical Research in The U.S.to Boost The Market
6.2.3 Preclinical Activities By Cros and Pharmaceutical R&D to Propel The Market
6.2.4 Growth in Rare Diseases to Create Demand For Mice Models
6.2.5 Mexico- Production Hub For Global Pharmaceutical Companies
6.3 Europe
6.3.1 Need For Better Mice Models to Trigger Investments and Innovation
6.3.2 Growth in Biosimilars Market Calls For Increased Preclinical Activities
6.3.3 Events Conducted By Animal Care Associations to Promote The Ethical Use of Mice
6.3.4 Increase in Tailored Mice Models For Cancer and Rare Disease Projects
6.4 Asia
6.4.1 Less Stringent Laws Creates A Potential For Outsourcing of Animal Models and Services
6.4.2 Growth in Translational Research in Singapore to Fuel The Market
6.4.3 Increasing R&D Activities Provide Impetus to Preclinical Research
6.4.4 Mandatory Animal Testing For All Pharmaceutical Drugs and Cosmetics in China
6.4.5 Growth in Regenerative Medicine, Biomedical, and Medical Research in Japan
6.4.6 Increase in Neuroscience Research in Malaysia
6.4.7 Government-Supported Strong Academic and Commercial R&D Activities in Taiwan
6.4.8 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
6.5 ROW
6.5.1 Pharmaceutical, Biotechnology, and Research industries in Brazil to Bolster The Market
6.5.2 Ongoing Biomedical Research Activities in Australia and New Zealand to Strengthen The Market
6.5.3 Favorable Business Environment For Pharmaceutical and Biotechnology industries in Saudi Arabia and Uae

7 Competitive Landscape (Page No. – 207)
7.1 Competitive Developments Mapping
7.2 Agreements, Partnerships, Collaborations, and Joint Ventures
7.3 Licensing
7.4 Grants and Funds
7.5 Marketing and Promotion
7.6 Expansions
7.7 Patents
7.8 Others

8 Company Profiles (Page No. – 245)
8.1 Ablexis, LLC
8.2 Charles River Laboratories, Inc.
8.3 Covance, Inc.
8.4 Crescendo Biologics,
8.5 Deltagen, Inc.
8.6 Genoway Sa
8.7 Harbour Antibodies Bv
8.8 Harlan Laboratories, Inc.
8.9 Immunogenes Ag
8.1 Ingenious Targeting Laboratory
8.11 Lexicon Pharmaceuticals, Inc.
8.12 Mirimus, Inc.
8.13 Taconic Farms, Inc.
8.14 The Jackson Laboratory
8.15 Transgenic, Inc.
8.16 Sage Labs

9 Preclinical Pipeline (Page No. – 299)

10 Industry Speaks (Page No. – 314)

11 Cost Assessment and Mouse Model Outlicensing/Buyer Companies Assessment (Page No. – 230)
11.1 Cost of Maintaining A Transgenic Mouse Colony
11.2 List of Mouse Model Outlicensing/Buyer Companies